|
Chiesi Pharmaceuticals - Pakistan
Chiesi Pakistan is one of the oldest affiliates of the Chiesi Group (1987) with the distinction of moving step by step in line with the dynamism of the Group. 2006 was another successful year at all operational levels. Overall ranking of Chiesi Pakistan is 43rd in the pharmaceutical market of Pakistan, with a market share of 0.76 %. The respiratory line, musculoskeletal area, and women’s health, along with other products, are the basic product portfolio of Chiesi Pakistan. In the respiratory line, due to innovative products and a highly skilled field force and staff, we have been able to record exceptional sales of our Clenil® range of products and nebulising solutions.
The same efficient elements have facilitated the affiliate to achieve highest sales of the No. 1 product, Brexin®. Due to a delay in the registration process, the launches of Curosurf® and Atimos® could not take place as planned in 2006.
Plans for 2007 are again highly ambitious and Chiesi Pakistan is determined outperform again the market. During the year 2007, another milestone will be the completion of the 20th successful year of operation in this country. It is indeed a matter of pride for all members of Chiesi Pakistan to celebrate this auspicious occasion in the most enthusiastic manner.
|
